First-line antihypertensive treatment in patients with pre-diabetes: Rationale, design and baseline results of the ADaPT investigation

BACKGROUND: Recent clinical trials reported conflicting results on the reduction of new-onset diabetes using RAS blocking agents. Therefore the role of these agents in preventing diabetes is still not well defined. Ramipril is an ACE inhibitor (ACEi), that has been shown to reduce cardiovascular eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zidek, Walter, Schrader, Joachim, Lüders, Stephan, Matthaei, Stephan, Hasslacher, Christoph, Hoyer, Joachim, Bramlage, Peter, Sturm, Claus-Dieter, Paar, W Dieter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529270/
https://www.ncbi.nlm.nih.gov/pubmed/18652658
http://dx.doi.org/10.1186/1475-2840-7-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529270/
https://www.ncbi.nlm.nih.gov/pubmed/18652658
http://dx.doi.org/10.1186/1475-2840-7-22

Ejemplares similares